TMCI

#3862
Treace Medical Concepts, Inc. Common Stock
2.13 USD
+5.97%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
2.13
2.13
Rango anual
1.17
7.78
Cambio diario
+5.97%
Variación mensual
+43.92%
Variación en los últimos 6 meses
-65.65%
Cambio anual
-67.73%
Cierres anteriores
2.01
Abrir
2.13
Bid
Ask
Mínimo
2.13
High
2.13
Volumen
66
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 137.58 M
  • Employee 450
  • Founded 2014
  • CEO N/A
  • Website www.treace.com
  • Headquarter Florida, United States
  • FIGI BBG00GQKR6M4
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.63
Relación precio/flujo de caja
0.73

Treace Medical Concepts Inc

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

Noticias